Literature DB >> 22825399

Diabetes: treating diabetic nephropathy-still an unresolved issue.

Mark E Cooper.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22825399     DOI： 10.1038/nrendo.2012.125

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN： 1759-5029            Impact factor:   43.330


× No keyword cloud information.
  10 in total

1.  Intensive diabetes therapy and glomerular filtration rate in type 1 diabetes.

Authors:  Ian H de Boer; Wanjie Sun; Patricia A Cleary; John M Lachin; Mark E Molitch; Michael W Steffes; Bernard Zinman
Journal:  N Engl J Med       Date:  2011-11-12       Impact factor: 91.245

2.  Association of HbA1c levels with vascular complications and death in patients with type 2 diabetes: evidence of glycaemic thresholds.

Authors:  S Zoungas; J Chalmers; T Ninomiya; Q Li; M E Cooper; S Colagiuri; G Fulcher; B E de Galan; S Harrap; P Hamet; S Heller; S MacMahon; M Marre; N Poulter; F Travert; A Patel; B Neal; M Woodward
Journal:  Diabetologia       Date:  2011-12-21       Impact factor: 10.122

3.  Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised study.

Authors:  P Gaede; P Vedel; H H Parving; O Pedersen
Journal:  Lancet       Date:  1999-02-20       Impact factor: 79.321

4.  Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes.

Authors:  David M Nathan; Patricia A Cleary; Jye-Yu C Backlund; Saul M Genuth; John M Lachin; Trevor J Orchard; Philip Raskin; Bernard Zinman
Journal:  N Engl J Med       Date:  2005-12-22       Impact factor: 91.245

5.  Causes of death among diabetic patients in Denmark.

Authors:  M B Hansen; M L Jensen; B Carstensen
Journal:  Diabetologia       Date:  2011-11-30       Impact factor: 10.122

Review 6.  Role of intensive glucose control in development of renal end points in type 2 diabetes mellitus: systematic review and meta-analysis intensive glucose control in type 2 diabetes.

Authors:  Steven G Coca; Faramarz Ismail-Beigi; Nowreen Haq; Harlan M Krumholz; Chirag R Parikh
Journal:  Arch Intern Med       Date:  2012-05-28

7.  Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial.

Authors:  Anushka Patel; S MacMahon; J Chalmers; B Neal; M Woodward; L Billot; S Harrap; N Poulter; M Marre; M Cooper; P Glasziou; D E Grobbee; P Hamet; S Heller; L S Liu; G Mancia; C E Mogensen; C Y Pan; A Rodgers; B Williams
Journal:  Lancet       Date:  2007-09-08       Impact factor: 79.321

8.  Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction.

Authors:  Nagesh S Anavekar; John J V McMurray; Eric J Velazquez; Scott D Solomon; Lars Kober; Jean-Lucien Rouleau; Harvey D White; Rolf Nordlander; Aldo Maggioni; Kenneth Dickstein; Steven Zelenkofske; Jeffrey D Leimberger; Robert M Califf; Marc A Pfeffer
Journal:  N Engl J Med       Date:  2004-09-23       Impact factor: 91.245

9.  10-year follow-up of intensive glucose control in type 2 diabetes.

Authors:  Rury R Holman; Sanjoy K Paul; M Angelyn Bethel; David R Matthews; H Andrew W Neil
Journal:  N Engl J Med       Date:  2008-09-10       Impact factor: 91.245

10.  Combined effects of routine blood pressure lowering and intensive glucose control on macrovascular and microvascular outcomes in patients with type 2 diabetes: New results from the ADVANCE trial.

Authors:  Sophia Zoungas; Bastiaan E de Galan; Toshiharu Ninomiya; Diederick Grobbee; Pavel Hamet; Simon Heller; Stephen MacMahon; Michel Marre; Bruce Neal; Anushka Patel; Mark Woodward; John Chalmers; Alan Cass; Paul Glasziou; Stephen Harrap; Liu Lisheng; Guiseppe Mancia; Avinesh Pillai; Neil Poulter; Vlado Perkovic; Florence Travert
Journal:  Diabetes Care       Date:  2009-08-03       Impact factor: 19.112
  10 in total
  16 in total

1.  Simvastatin ameliorates low-dose streptozotocin-induced type 2 diabetic nephropathy in an experimental rat model.

Authors:  Siwei Zhang; Huali Xu; Xiaofeng Yu; Yuchen Wang; Fanfan Sun; Dayuan Sui
Journal:  Int J Clin Exp Med       Date:  2015-04-15

2.  Angiotensin type 1 receptor mediates renal production and conversion of prostaglandins E2 to F2α in conscious diabetic rats.

Authors:  Peter M Abadir; Helmy M Siragy
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2015-07-20       Impact factor: 1.636

3.  Functional Role of SUV39H1 in Human Renal Tubular Epithelial Cells Under High-glucose Ambiance.

Authors:  Jiayi Wang; Wenzhe Yan; Xiaofei Peng; Yafeng Jiang; Liyu He; Youming Peng; Xian Chen; Muyao Ye; Hui Zhuo
Journal:  Inflammation       Date:  2018-02       Impact factor: 4.092

Review 4.  Inflammatory cytokines in diabetic nephropathy.

Authors:  Javier Donate-Correa; Ernesto Martín-Núñez; Mercedes Muros-de-Fuentes; Carmen Mora-Fernández; Juan F Navarro-González
Journal:  J Diabetes Res       Date:  2015-02-15       Impact factor: 4.011

5.  Xiaokeping mixture inhibits diabetic nephropathy in streptozotocin-induced rats through blocking TGF-β1/Smad7 signaling.

Authors:  Chuanwei Xin; Zhongni Xia; Cheng Jiang; Mengmeng Lin; Gonghua Li
Journal:  Drug Des Devel Ther       Date:  2015-11-30       Impact factor: 4.162

6.  The anti-inflammatory and antifibrotic effects of Coreopsis tinctoria Nutt on high-glucose-fat diet and streptozotocin-induced diabetic renal damage in rats.

Authors:  Lan Yao; Linlin Li; Xinxia Li; Hui Li; Yujie Zhang; Rui Zhang; Jian Wang; Xinmin Mao
Journal:  BMC Complement Altern Med       Date:  2015-09-07       Impact factor: 3.659

7.  Corosolic acid inhibits the proliferation of glomerular mesangial cells and protects against diabetic renal damage.

Authors:  Xiao-Qiang Li; Wen Tian; Xiao-Xiao Liu; Kai Zhang; Jun-Cheng Huo; Wen-Juan Liu; Ping Li; Xiong Xiao; Ming-Gao Zhao; Wei Cao
Journal:  Sci Rep       Date:  2016-05-27       Impact factor: 4.379

8.  Renal-protective effect of thalidomide in streptozotocin-induced diabetic rats through anti-inflammatory pathway.

Authors:  Hongxia Zhang; Yanlan Yang; Yanqin Wang; Baodong Wang; Rongshan Li
Journal:  Drug Des Devel Ther       Date:  2018-01-09       Impact factor: 4.162

9.  Protective effect of berberine on renal fibrosis caused by diabetic nephropathy.

Authors:  Zhong Li; Wei Zhang
Journal:  Mol Med Rep       Date:  2017-06-07       Impact factor: 2.952

10.  Interleukin-22 ameliorated renal injury and fibrosis in diabetic nephropathy through inhibition of NLRP3 inflammasome activation.

Authors:  Shaofei Wang; Yubin Li; Jiajun Fan; Xuyao Zhang; Jingyun Luan; Qi Bian; Tao Ding; Yichen Wang; Ziyu Wang; Ping Song; Daxiang Cui; Xiaobin Mei; Dianwen Ju
Journal:  Cell Death Dis       Date:  2017-07-20       Impact factor: 8.469
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.